The Research Of Business Models In Chinese Pharmaceutical Enterprises

Based on the defines of business model and the constituent elements of the research survey in the past, this paper proposed that: the activities of business model were a number of different operation methods and forms to enhance the value for the realization of the business in the continuous cycle.According to the value of activities business process and in combination with the features of pharmaceutical companies industry, the pharmaceutical companies were divided into six sub-models in this paper: R&D model, asset model, sales model, logistic model, market model, performance model, and with respect to their refined, summarized and discussed.After an overall business model classification of pharmaceutical enterprises in China, 48 Chinese listed companies were selected as samples of furniture representative, sorting out the relevant financial data analysis system for the establishment of indicators, using of factor analysis to evaluate the performance of the pharmaceutical enterprises that selected. Meanwhile, the paper proposes the use of a commercial pattern classification method to extract the business model of each sample type, analysis of the relationships with business performance, and discuss the match relationship between the business models and corporate performance.The following were found through discussion: for their own characteristics, Chinese pharmaceutical enterprises have some characteristics from the point of view, the external similarity, the internal morphological diversity, focus, similar differences and characteristics such as internal links; and because business models and business performance have their own characteristics, high-performance enterprise and business model has three matching relations, high -performance and comprehensive enterprise business model matching, high-performance business model and business application matching, high-performance business model and sustainability matching.Furthermore, the paper also adopted the international pharmaceutical industry environment and the domestic pharmaceutical industry environment analysis, to give the matching relationship a strategic explanation from the three corporate performance of Chinese pharmaceutical and business models: business model impact on competitive advantage to further the business performance; business models can affect the core competence to promote business performance; business models can foster business the advantage to improve the business performance. Finally, put forward own proposals of Chinese pharmaceutical enterprises development strategy from a business perspective and the industrial policy view.